Last Updated on February 23, 2023
The authorities of Hong Kong will introduce new COVID-19 quarantine requirements on 1 October 2022
The authorities of Hong Kong announced that the jurisdiction will lift the requirement to undergo a hotel quarantine upon arrival effective 26 September 2022. Eligible foreign national travelers have the option to undergo an at-home medical surveillance period for the three days or a hotel of their choice after a negative PCR test result has been produced upon arrival.
Travelers who receive a negative test result will be given an amber code in the LeaveHomeSafe mobile app. This will mean restricted entry into certain locations but will allow the traveler to go out during the at-home medical surveillance period.
Once the medical surveillance period is complete, travelers will continue to be required to self-monitor for an additional four days.
Travelers will need to undergo rapid antigen testing daily and PCR testing once every two days throughout the at-home medical surveillance period and the additional four-day self-monitoring period.
What are the Changes?
The authorities of Hong Kong will introduce new COVID-19 quarantine measures on 1 October 2022 and remove the requirement to undergo a hotel facility-based quarantine. Previously, all eligible travelers were required to undergo the quarantine period in a government-approved hotel facility.
This article was published on 26 September 2022 and may not be the most recent update concerning COVID-19 entrance restrictions, testing requirements and quarantine measurers. For the most recent updates be sure to check our Global Mobility Resource Center.
Content in this publication is for informational purposes only and not intended as legal advice, nor should it be relied on as such. For additional information on the issues discussed, consult an attorney at one of the two U.S. Law Firms working with the Envoy Platform or another qualified professional. On non-U.S. immigration issues, consult an Envoy global immigration service provider or another qualified representative.